Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research
14 août 2023 06h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023...
Hydrocephalus Market Industry Forecast Report 2022, Featuring Profiles of Aesculap, Integra Lifesciences, Karl Storz, Proteses, Medtronic and Natus Medical
09 mai 2022 04h08 HE
|
Research and Markets
Dublin, May 09, 2022 (GLOBE NEWSWIRE) -- The "Hydrocephalus Market by Cause, Type, Diagnosis, Treatment and Age: Global Opportunity Analysis and Industry Forecast, 2021-2030" report has been added...
Cerebrospinal Fluid Management Market Size, $2.61Bn by 2028 Lead by CSF Shunts, 5.3% CAGR - Exclusive Research Report by The Insight Partners
24 janv. 2022 07h32 HE
|
The Insight Partners
New York, Jan. 24, 2022 (GLOBE NEWSWIRE) -- According to our new research study on “Cerebrospinal Fluid Management Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product (CSF...
Cerebrospinal Fluid Management Market Size to Reach USD 2.00 Bn In 2027 | Growing Usage of Shunting Processes, Increasing Adoption of Minimally Invasive Procedures For Surgery are Key Factors Driving Industry Growth, says Emergen Research
10 mai 2021 17h00 HE
|
Emergen Research
Vancouver, British Columbia, May 10, 2021 (GLOBE NEWSWIRE) -- The global cerebrospinal fluid management market is expected to reach USD 2.00 Billion by 2027, according to a current analysis by...
Cerebrospinal Fluid (CSF) Management Market To Reach USD 2.11 Billion By 2026
01 avr. 2019 11h51 HE
|
Reports And Data
The market is driven by the increase in investment in research and development in the field of cerebrospinal fluid management and increasing geriatric population worldwide Market Size – USD 1.45...
Endonovo Therapeutics Announces Enrollment of First Patient in Clinical Study at the University of New Mexico for Treating Traumatic Brain Injury Using Its Electroceutical™ Therapy
14 juin 2018 08h30 HE
|
Endonovo Therapeutics, Inc.
LOS ANGELES, CA, June 14, 2018 (GLOBE NEWSWIRE) -- Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...